Apr 28, 2020

Pivotal is providing its specialized clinical research services for the conduct of a clinical trial in patients with COVID-19

Mar 03, 2020

Pivotal Acquires Akcelis, an Industry Leader in Patient Engagement, Recruitment and Retention

New patients´ enrollment model to accelerate drug development

Feb 12, 2020

PIVOTAL HAS PARTICIPATED IN THE 38TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE

The annual conference was held in San Francisco (California)

Feb 11, 2020

Pivotal to provide services to Lucid Diagnostics´ clinical studies for its GI in-vitro diagnostics EsoGuard™ and EsoCheck™ to facilitate diagnosis of Barrett’s Esophagus

Nov 25, 2019

PIVOTAL AT THE GDPR SUMMIT CELEBRATED IN BRUSSELS

PIVOTAL’s QA & Compliance Director Francisco Calvo recently participated in Brussels in an interactive conference on GDPR.

Oct 08, 2019

PIVOTAL AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO)

Pivotal has recently participated with a booth number 451 at the ESMO congress in Barcelona, which ended on Tuesday, October 1st 2019.

Sep 06, 2019

PIVOTAL WILL ATTEND THE 2019 EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) CONGRESS IN BARCELONA, SPAIN

Jul 03, 2019

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer

Collaboration will allow patients in the EU and US to access previously inaccessible investigational cancer therapies for the first time

May 27, 2019

Pivotal will attend again the ASCO Annual Meeting

The American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago, (USA)

Feb 06, 2019

Pivotal starts enrolment in a phase II clinical trial in patients with von Hippel-Lindau (VHL) disease developing renal cell cancer

New collaboration aims to further accelerate the delivery of novel treatments for difficult-to-treat cancers